Colchicine more effective than placebo for recurrent pericarditis Colchicine.
Our goal was to test these recommendations in a multicentre double-blind randomised placebo-managed trial.’ Indeed, it had been based on such non-randomised observational results that colchicine was recommended for the treatment of recurrent pericarditis in the 2004 guidelines on pericardial diseases of the European Society of Cardiology. The CORP trial, an unbiased non-sponsored research and the first multicentre double-blind randomised trial of colchicine in the secondary prevention of pericarditis, was performed in four centres in Italy and recruited 120 consecutive patients with a first bout of recurrent pericarditis.Medcor data is delivered straight into Broadspire’s systems. Both Medcor and Broadspire can load employee data and work to ensure accuracy together. Broadspire holds URAC accreditations in case management, independent review business, health and workers payment and utilization management. ‘I’m excited to provide our clients a means of immediately addressing small accidental injuries at any worksite,’ Lisenbey said. ‘Medcor’s proprietary damage triage process has constantly led the industry given that they introduced this program.